Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice

Cardiovasc Diabetol. 2024 Apr 25;23(1):138. doi: 10.1186/s12933-024-02239-6.

Abstract

Background: Neutral cholesterol ester hydrolase 1 (NCEH1) plays a critical role in the regulation of cholesterol ester metabolism. Deficiency of NCHE1 accelerated atherosclerotic lesion formation in mice. Nonetheless, the role of NCEH1 in endothelial dysfunction associated with diabetes has not been explored. The present study sought to investigate whether NCEH1 improved endothelial function in diabetes, and the underlying mechanisms were explored.

Methods: The expression and activity of NCEH1 were determined in obese mice with high-fat diet (HFD) feeding, high glucose (HG)-induced mouse aortae or primary endothelial cells (ECs). Endothelium-dependent relaxation (EDR) in aortae response to acetylcholine (Ach) was measured.

Results: Results showed that the expression and activity of NCEH1 were lower in HFD-induced mouse aortae, HG-exposed mouse aortae ex vivo, and HG-incubated primary ECs. HG exposure reduced EDR in mouse aortae, which was exaggerated by endothelial-specific deficiency of NCEH1, whereas NCEH1 overexpression restored the impaired EDR. Similar results were observed in HFD mice. Mechanically, NCEH1 ameliorated the disrupted EDR by dissociating endothelial nitric oxide synthase (eNOS) from caveolin-1 (Cav-1), leading to eNOS activation and nitric oxide (NO) release. Moreover, interaction of NCEH1 with the E3 ubiquitin-protein ligase ZNRF1 led to the degradation of Cav-1 through the ubiquitination pathway. Silencing Cav-1 and upregulating ZNRF1 were sufficient to improve EDR of diabetic aortas, while overexpression of Cav-1 and downregulation of ZNRF1 abolished the effects of NCEH1 on endothelial function in diabetes. Thus, NCEH1 preserves endothelial function through increasing NO bioavailability secondary to the disruption of the Cav-1/eNOS complex in the endothelium of diabetic mice, depending on ZNRF1-induced ubiquitination of Cav-1.

Conclusions: NCEH1 may be a promising candidate for the prevention and treatment of vascular complications of diabetes.

Keywords: Diabetes; Endothelial dysfunction; NCEH1; Nitric oxide; eNOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / enzymology
  • Aorta / metabolism
  • Aorta / pathology
  • Aorta / physiopathology
  • Caveolin 1* / deficiency
  • Caveolin 1* / genetics
  • Caveolin 1* / metabolism
  • Cells, Cultured
  • Diabetes Mellitus, Experimental / enzymology
  • Diabetes Mellitus, Experimental / physiopathology
  • Diet, High-Fat*
  • Endothelial Cells* / drug effects
  • Endothelial Cells* / enzymology
  • Endothelial Cells* / metabolism
  • Endothelium, Vascular* / drug effects
  • Endothelium, Vascular* / enzymology
  • Endothelium, Vascular* / metabolism
  • Endothelium, Vascular* / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Mice, Knockout
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III* / metabolism
  • Obesity / enzymology
  • Obesity / metabolism
  • Obesity / physiopathology
  • Signal Transduction
  • Sterol Esterase / genetics
  • Sterol Esterase / metabolism
  • Ubiquitination
  • Vasodilation* / drug effects

Substances

  • Cav1 protein, mouse
  • Caveolin 1
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Sterol Esterase
  • Nceh1 protein, mouse